Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731408 | SCV000859220 | uncertain significance | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001399219 | SCV001601004 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2020-10-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000731408 | SCV002544148 | uncertain significance | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | TTN: PM2, BP4 |
Ambry Genetics | RCV003353011 | SCV004063439 | uncertain significance | Cardiovascular phenotype | 2023-07-19 | criteria provided, single submitter | clinical testing | The c.37478-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 137 in the TTN gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Diagnostic Laboratory, |
RCV000731408 | SCV001740110 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000731408 | SCV001931549 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000731408 | SCV001957931 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727800 | SCV001971038 | benign | not specified | no assertion criteria provided | clinical testing |